Ikena Oncology, INC. (IMA) SEC Filings — 2024

Filings

• Ikena Oncology Files 8-K: Material Agreements, Control Changes — 8-K · Dec 23, 2024
• Ikena Oncology, INC. SC 13G Filing — SC 13G · Nov 14, 2024
• Ikena Oncology, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• Ikena Oncology Q3 2024 Update — 10-Q · Nov 7, 2024
• Ikena Oncology Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Ikena Oncology Appoints New Chief Medical Officer — 8-K · Jul 12, 2024
• Ikena Oncology Reports on Shareholder Vote — 8-K · Jun 10, 2024
• Ikena Oncology Terminates Bristol Myers Squibb Deal for IK-750 — 8-K · May 28, 2024
• Ikena Oncology, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Ikena Oncology 2024 Annual Meeting Proxy Statement — DEFA14A · Apr 26, 2024
• Ikena Oncology Announces 2024 Annual Meeting of Stockholders on June 7 — DEF 14A · Apr 26, 2024
• Ikena Oncology Files 2023 Annual Report on Form 10-K — 10-K · Mar 12, 2024
• Ikena Oncology, INC. SC 13G/A Filing — SC 13G/A · Mar 11, 2024
• Ikena Oncology Reports Executive Changes and Compensation Arrangements — 8-K · Feb 21, 2024
• Ikena Oncology, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Ikena Oncology, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Ikena Oncology, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• FMR LLC & Abigail Johnson Maintain 9.545% Stake in Ikena Oncology — SC 13G/A · Feb 9, 2024
• Ikena Oncology Relocates HQ to 50 Northern Ave, Cuts Costs — 8-K · Jan 18, 2024